thyroxine has been researched along with allopurinol in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Siegel, NJ | 1 |
| Baret, A; Fert, V | 1 |
| Seymour, AM; Smolenski, RT; Yacoub, MH | 1 |
| Grabowska-Maślanka, H; Janik, A | 1 |
| Hayashi, R; Ishizuki, Y; Itoh, M; Iwase, K; Kakizawa, H; Makino, M; Mano, T; Nagasaka, A; Nagata, M; Nakano, I; Shinohara, R; Tsugawa, T; Uchimura, K; Watanabe, F | 1 |
| Blandizzi, C; Colucci, R; Daghini, E; Dardano, A; Del Tacca, M; Duranti, E; Fornai, M; Ghisu, N; Monzani, F; Polini, A; Taddei, S; Versari, D; Virdis, A | 1 |
| Akyildiz, M; Genc Simsek, N; Icoz, G; Makay, O; Ozgen, G; Yenisey, C; Yetkin, E | 1 |
| Chatzis, MK; Kasabalis, D; Petanides, T; Saridomichelakis, MN; Steiner, JM; Suchodolski, JS; Xenoulis, PG | 1 |
| Ahmed, AA; Elnakish, MT; Gearinger, RL; Janssen, PM; Mohler, PJ; Rastogi, N; Saad, NS; Schultz, EJ | 1 |
| Chang, DJ; Choi, IY; Choi, W; Chung, YW; Kang, DY; Kim, H; Ko, SJ; Oh, JS; Yang, HJ; Yang, YS; Yoo, S | 1 |
1 review(s) available for thyroxine and allopurinol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
14 other study(ies) available for thyroxine and allopurinol
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Management of acute renal failure in children.
Topics: Acute Kidney Injury; Allopurinol; Calcium Channel Blockers; Child; Humans; Thyroid Hormones; Thyroxine | 1990 |
T4 and ultrasensitive TSH immunoassays using luminescent enhanced xanthine oxidase assay.
Topics: Humans; Immunoenzyme Techniques; Kinetics; Luminescent Measurements; Luminol; Radioimmunoassay; Reference Standards; Thyrotropin; Thyroxine; Xanthine Oxidase | 1989 |
Hyperthyroidism increases adenosine transport and metabolism in the rat heart.
Topics: Adenine; Adenosine; Adenosine Deaminase; Adenosine Kinase; Adenosylhomocysteinase; AMP Deaminase; Animals; Biological Transport; Body Weight; Disease Models, Animal; Heart; Hydrolases; Hyperthyroidism; Male; Myocardium; Nucleotidases; Organ Size; Phosphorylation; Purine-Nucleoside Phosphorylase; Rats; Thyroxine; Time Factors; Xanthine Oxidase | 1995 |
[The effect of antioxidants on lipid metabolism in myocardium in experimental hyperthyroxinemic conditions].
Topics: Allopurinol; Animals; Antimetabolites; Antioxidants; Ascorbic Acid; Deferoxamine; Female; Heart; Hyperthyroxinemia; Injections, Intraperitoneal; Lipid Metabolism; Male; Myocardium; Phospholipids; Rats; Rats, Wistar; Siderophores; Thyroxine; Triglycerides | 1996 |
Lipid peroxidation levels in rat cardiac muscle are affected by age and thyroid status.
Topics: Aging; Analysis of Variance; Animals; Antithyroid Agents; Glutathione Peroxidase; Hyperthyroidism; Hypothyroidism; Lipid Peroxidation; Male; Malondialdehyde; Methimazole; Myocardium; Rats; Rats, Wistar; Superoxide Dismutase; Thyroid Diseases; Thyroid Gland; Thyroxine; Vitamin E; Xanthine Oxidase | 2000 |
Inducible nitric oxide synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats.
Topics: Allopurinol; Animals; Ascorbic Acid; Endothelium, Vascular; Enzyme Inhibitors; Hypothyroidism; Male; Mesenteric Arteries; Methimazole; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Superoxides; Thyroxine; Vasodilation | 2009 |
The role of allopurinol on oxidative stress in experimental hyperthyroidism.
Topics: Allopurinol; Animals; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Hyperthyroidism; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Thyroxine; Xanthine Oxidase | 2009 |
Thyroid function in 36 dogs with leishmaniosis due to Leishmania infantum before and during treatment with allopurinol with or without meglumine antimonate.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Hypothyroidism; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Thyrotropin; Thyroxine | 2013 |
Differential involvement of various sources of reactive oxygen species in thyroxin-induced hemodynamic changes and contractile dysfunction of the heart and diaphragm muscles.
Topics: Animals; Diaphragm; Echocardiography; Heart; Hemodynamics; Male; Mice; Mitochondria; Muscle Contraction; NADPH Oxidases; Oxidative Stress; Reactive Oxygen Species; Thyroxine; Ventricular Dysfunction, Left; Xanthine Oxidase | 2015 |
Association between the use of allopurinol and risk of increased thyroid-stimulating hormone level.
Topics: Adult; Allopurinol; Case-Control Studies; Female; Humans; Hyperthyroidism; Hypothyroidism; Male; Odds Ratio; Republic of Korea; Retrospective Studies; Rheumatology; Risk; Risk Factors; Thyroid Function Tests; Thyrotropin; Thyroxine; Young Adult | 2021 |